Officer received an award of 5,669 RGEN derivative securities | OQRO Insider tradesWhy it stands out
Compensation award — excluded from discretionary-purchase analysis.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
All the details
Dates, kept separate
- Transaction date
- Mar 5, 2026
- Reporting period
- Not applicable
- Filed with the SEC
- Mar 23, 2026
OfficerGrant / award
Context
- Classification
grant award
Code A — grant or award
- Planned / mechanical clue
Footnote references vesting of compensation awards
Only flagged when a footnote says so; never inferred
Source receipt
- Record ID
- 0001193125-26-119047
- Filed / recorded
Added to OQROOct 6, 2026, 8:46 PM UTC Data qualityVerified: identifiers matched exactly Reporting personRalf Kuriyel Officer titleSenior VP, R&D SecurityStock Option (Right to Buy) TableDerivative (Table II) Transaction dateMar 5, 2026 Acquired / disposedAcquired (A) Footnotes from the filing
- One third of the stock options will vest and become exercisable annually on March 5, 2027, March 5, 2028, and March 5, 2029.
Around the same time
CEO sold ~$536K of Repligen
Scheduled in advanceCompensation award — excluded from discretionary-purchase analysis.
Compensation award — excluded from discretionary-purchase analysis.